4 Small-Cap Biotech Stars

It has been a nice little run for the previously beaten down biotech/biopharma sectors so far in 2017. February saw the main biotech indices rise some 10%, in one of their best monthly performances over the past few years. An uptick in M&A activity, as well as the prospect of tax and regulatory reform, have buoyed sentiment on this part of the market early in the year.

Biotech is at the very top end of a trading range it has been locked in for more than a year now. I think we need another M&A deal, or two, to finally break through this resistance level decisively. Doing so looked promising in early trading yesterday, but an afternoon selloff put the main biotech indices right under this resistance ceiling, once again, by the end of the day....392 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.